ISEC Healthcare (40T) investor relations material

Executive summary

• Q3 2026 revenue rose 6% YoY to $21.90m, while net profit fell 18% to $3.21m; 9M revenue grew 8% to $62.97m and net profit declined 13% to $9.36m.

• Higher doctor remuneration, consumables, administrative costs and FX losses weighed on earnings and margins; new centre openings and patient growth in Malaysia supported revenue.

Financial highlights

• Q3 gross profit increased 1% YoY to $9.21m; profit before tax fell 8% to $4.75m and total comprehensive income declined 54% to $2.14m.

• 9M gross profit was $26.14m, up 1%; profit before tax fell 8% to $12.99m and total comprehensive income fell 23% to $8.58m.

• 9M income tax expense increased 6% YoY to $3.62m; parent-attributable profit declined 12% to $9.40m.

Outlook and guidance

• New KL Medical Centre operations are expected to commence by 2027, subject to completion of fit-out, regulatory approvals and no unforeseen delays.

• ISEC Batu Pahat is expected to commence operations in Q1 2027, subject to other pre-operational requirements.

• Fit-out work is underway at the new Batu Pahat centre; the group continues to pursue opportunities in Vietnam and Myanmar while strengthening Singapore and Malaysia operations.